首页> 美国卫生研究院文献>Cell Death and Differentiation >MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma
【2h】

MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma

机译:MALAT1-KTN1-EGFR调控轴促进皮肤鳞状细胞癌的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Long noncoding RNAs (LncRNAs), including MALAT1, are critical regulators of tumor development. However, the roles and molecular mechanisms of LncRNAs in cutaneous squamous cell carcinoma (cSCC) remain underexplored. In this study, functional studies using in vitro cellular and in vivo xenograft models confirmed the pro-carcinogenic roles of MALAT1 in cSCC. Further, MALAT1 was identified to regulate epidermal growth factor receptor (EGFR) protein expression but did not affect EGFR mRNA expression. Transcriptomic sequencing identified kinectin 1 (KTN1) as the key mediator for MALAT1 regulation of EGFR. Mechanistic study revealed that MALAT1 interacts with c-MYC to form a complex and directly binds to the promoter region of KTN1 gene and enhances its transactivation to positively regulate EGFR protein expression. Our findings, therefore, establish a novel c-MYC-assisted MALAT1-KTN1-EGFR axis, which contributes to cSCC development and may serve as novel target for therapeutic intervention.
机译:包括MALAT1在内的长非编码RNA(LncRNA)是肿瘤发展的关键调节因子。然而,LncRNA在皮肤鳞状细胞癌(cSCC)中的作用和分子机制仍未得到充分研究。在这项研究中,使用体外细胞和体内异种移植模型的功能研究证实了MALAT1在cSCC中的致癌作用。此外,已确定MALAT1调节表皮生长因子受体(EGFR)蛋白的表达,但不影响EGFR mRNA的表达。转录组测序确定kinectin 1(KTN1)是MALAT1调节EGFR的关键介质。机理研究表明,MALAT1与c-MYC相互作用形成复合物,并直接与KTN1基因的启动子区域结合,并增强其反式激活作用,从而正向调节EGFR蛋白的表达。因此,我们的发现建立了新型的c-MYC辅助的MALAT1-KTN1-EGFR轴,这有助于cSCC的发展,并可以作为治疗干预的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号